HealthHealth & Wellness
Eli Lilly and Company wins FDA approval for weekly Onswik insulin
FDA cleared the weekly basal insulin for adults with type 2 diabetes on Sept. 24; Lilly expects the U.S. pen in the coming months.
Montage Gold pours 1,140 ounces at Koné ahead of schedule
The Sept. 26 first pour came before the original second-quarter 2027 schedule; the oxide circuit is targeted for commercial production in late 2026.
EnergyUS
Fervo Energy exports first power from 33 MW Utah geothermal block
The first Cape Station block is due for contractual commercial operation by Oct. 1, while two more blocks target Jan. 1, 2027.
Analysis
Cipher Digital reports AI lab commitment to enter later Barber Lake lease
An unnamed AI lab committed to enter a separate ten-year Barber Lake lease after Fluidstack's term; first rent commencement is expected in the fourth quarter of 2026.
Mining
CNSX: ASHLAshley Gold reports 3.333 g/t over 60 metres at Tak
Hole TAK-26-16 includes 229 grams per tonne gold over 0.65 metre, with results from four Phase III holes pending.
EnergyTechnology
CBRE Group signs five-year deal to operate Fermi data centre
The term starts when Building One is ready for service; Fermi gave no date or contract value in its Sept. 24 announcement.
MiningGold
i‑80 Gold targets 75K annual ounces in Granite Creek study
The first 556,500-ounce reserve backs an 8.5-year Granite Creek plan, with Lone Tree processing scheduled for late 2027.
Energy
TSE: ATSOPG's Sept. 25 supplier post names ATS's tooling and a 125,000-square-foot facility addition without stating a contract value or delivery date.
Mining
CNSX: LIBRSIDEX and NQ Mining Investment lead the flow-through sale, priced at C$0.145 a share and expected to close about Sept. 29.
Analysis
Canopy Growth delays share consolidation vote after meeting lacks quorum
The Sept. 25 meeting lacked quorum, leaving shareholders until 9 a.m. EDT on Oct. 23 to submit proxies before the reconvened vote.
Latest
WISeKey expects October 2 merger and October 5 WISeQey trading
The Swiss cybersecurity group expects Oct. 2 to be the last session for its existing ADSs and Class B shares before a planned WISeQey listing.
Rexel agrees to buy GCG at US$1.4B enterprise value
Rexel plans about €800M in cash and debt and may raise up to €500M in equity before a targeted 2026 year-end close.
Akamai signs US$11.6B Anthropic cloud deal with US$5.5B buildout
The seven-year CPU services agreement carries delivery conditions, a preferred-share warrant and a projected late 2027 service start.
REGENXBIO reports three-year retinopathy improvement in 6 of 10
The small ALTITUDE follow-up lacks a control comparison; the dose is being tested in the sham-controlled NAAVIGATE trial.
Cresco Labs puts three restructuring resolutions to October 30 vote
Holders will weigh a new parent company, a Delaware move and a voting-share sunset extension as Cresco pursues a potential U.S. listing.
Clearmind Medicine reports three published US patent applications
The applications pair LSD, ketamine and ibogaine with N-acylethanolamines, while the scope of any patent rights remains undecided.
Mentioned this week
Mining & Critical Minerals
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
MiningGold
Lode Gold Resources begins Frankfurt trading after $9.72M July placement
Its July placement issued 35.98 million shares and matching warrants, while the latest notice disclosed $334,577 in finder fees.
Health & Science
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
Health
AMS: PHARMThe application seeks dosing for smaller children with APDS, and the FDA set Jan. 30, 2027 as its target action date.
More in Health
Markets & Technology
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
BitcoinCrypto/Blockchain
Bitdeer Technologies Group sells 288.4 BTC, has zero pure holdings
The Sept. 25 weekly update lists 288.1 BTC mined and zero net coins added; Friday's Nasdaq close predates the post.
Technology
NYSE: ETNEaton agrees to acquire COL Group for €810M in European power deal
COL forecasts €250 million in 2027 sales; Eaton expects the acquisition to close in the first quarter, subject to approvals.
Energy
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Energy
NYSE: WMBA Sept. 24 federal notice opens intervention in Transco's Pennsylvania pipeline application, while Williams targets late 2027 service.
Uranium
NYSEAMERICAN: JAGUSelected historic core from Colombia also held magnet rare earth oxides, but continuity and recovery remain untested.
Uranium
CVE: FUUThe 1-for-10 plan has shareholder approval but still needs TSX Venture Exchange acceptance; Dev Randhawa becomes executive chair.
Cannabis & Psychedelics
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Cannabis
TSE: CURACuraleaf urged a signature on Sept. 23; A10698B would let regulators seek suspensions and impose daily civil penalties.
Cannabis
TSE: ACBAurora cites missing pro forma financials, a French-language notice and the mandatory 105-day deposit period in its ASC application.
Health
NASDAQ: GRALAdvisers voted 10 to 0 on safety and 6 to 4 on effectiveness; the FDA has not set a date for its final decision.
Cannabis
NASDAQ: IMCCA 51 per cent stake in a Polish drone company remains a non-binding proposal, while the registered share sale is expected to close Sept. 24.